GLP-1 AGONISTS CAN PREVENT LIVER DISEASE PROGRESSION IN PATIENTS WITH METABOLIC AND ALCOHOL-ASSOCIATED LIVER DISEASE (METALD).

被引：0
|
作者：
Gougol, Amir
Pike, C. William
Khanna, Niloufar
Kwo, Paul Yien
机构：
来源：
GASTROENTEROLOGY | 2024年 / 166卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
749
引用
收藏
页码：S1556 / S1556
页数：1
相关论文
共 50 条
  • [1] Metabolic and alcohol-associated liver disease (MetALD): a representation of duality
    Hector Leal-Lassalle
    Olga Estévez-Vázquez
    Francisco Javier Cubero
    Yulia A. Nevzorova
    npj Gut and Liver, 2 (1):
  • [2] Therapeutic Potential of GLP-1 Receptor Agonists in Metabolic Associated Steatotic Liver Disease
    Nowak, Klaudia
    Lupina, Krzysztof
    Romac, Anna
    Kalisz, Aleksandra
    Ilkiewicz, Lucja
    Janczura, Jakub
    ANNALS OF PHARMACOTHERAPY, 2025,
  • [3] Inflammation in alcohol-associated liver disease progression
    Lotersztajn, Sophie
    Riva, Antonio
    Wang, Sai
    Dooley, Steven
    Chokshi, Shilpa
    Gao, Bin
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2022, 60 (01): : 58 - 66
  • [4] NALTREXONE USE IN PATIENTS WITH COMBINED METABOLIC AND ALCOHOL-ASSOCIATED LIVER DISEASE (METALD), PROPENSITY SCORE MATCHED STUDY
    Gougol, Amir Hossein
    Kwo, Paul
    Pike, C.
    Gombar, Saurabh
    Hui, Gavin
    HEPATOLOGY, 2024, 80
  • [5] Impact of GLP-1 Receptor Agonists on Alcohol-Related Liver Disease Development and Progression in Alcohol Use Disorder
    Kuo, Chia-Chih
    Li, Chun-Hsien
    Chuang, Min-Hsiang
    Huang, Po-Yu
    Kuo, Hsing-Tao
    Lai, Chih-Cheng
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2025,
  • [6] Alcohol-Associated Liver Disease
    Jophlin, Loretta L.
    Singal, Ashwani K.
    Shah, Vijay H.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2025, 120 (03): : 495 - 499
  • [7] Alcohol-associated liver disease
    Mackowiak, Bryan
    Fu, Yaojie
    Maccioni, Luca
    Gao, Bin
    JOURNAL OF CLINICAL INVESTIGATION, 2024, 134 (03):
  • [8] Letter: Association of myokines with disease progression and outcomes in patients with alcohol-associated liver disease
    Lv, Jianyu
    Ying, Yize
    Du, Chenfei
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2024, 60 (10) : 1475 - 1476
  • [9] GLP-1 receptor agonists: A new frontier in combating metabolic liver disease complications
    Fatima, Ayesha
    Maryam, Ayesha
    Nadeem, Muhammad Salman
    Asmat, Kashaf Noor
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2024, 60 (10) : 1499 - 1500
  • [10] High-Sensitivity C-Reactive Protein Levels in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), Metabolic Alcohol-Associated Liver Disease (MetALD), and Alcoholic Liver Disease (ALD) with Metabolic Dysfunction
    Baek, Seong-Uk
    Yoon, Jin-Ha
    BIOMOLECULES, 2024, 14 (11)
12345